You just read:

Codiak BioSciences Presents First Data on exoSTING - A Novel Engineered Exosome Therapeutic Targeting Checkpoint Refractory Tumors at the Society for Immunotherapy of Cancer's 33rd Annual Meeting

News provided by

Codiak BioSciences, Inc.

Nov 06, 2018, 08:00 ET